Plasma cell leukemia producing monoclonal immunoglobulin e

International Journal of Hematology

Volumn 90, Issue 3, 2009, Pages 402-406

  Takemura, Yuzuru ^a   Ikeda, Masanobu ^a   Kobayashi, Kahori ^a,b   Nakazawa, Yuji ^a   Mori, Yuichi ^a   Mitsuishi, Toshimi ^a   Ishigame, Hiroki ^a   Kameko, Fumiko ^b   Fujita, Kiyotaka ^c   Ichinohasama, Ryo ^d  

^a Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c CHIBA INSTITUTE OF SCIENCE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone lesion; Cellular adhesion molecules; Immunoglobulin E (IgE); Multiple myeloma; Plasma cell leukemia

Indexed keywords

ALPHA5 INTEGRIN; CALCIUM; CD19 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CYCLIN D1; DEXAMETHASONE; IMMUNOGLOBULIN E; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CASE REPORT; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CONSCIOUSNESS; CYTOPLASM; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; LABORATORY TEST; LOW BACK PAIN; MALE; MULTIPLE CYCLE TREATMENT; OSTEOLYSIS; PHENOTYPE; PLASMA CELL DYSCRASIA; PLASMA CELL LEUKEMIA; PROTEIN EXPRESSION; RARE DISEASE; TUMOR CELL; TUMOR GROWTH;

AGED; ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN KAPPA-CHAINS; LEUKEMIA, PLASMA CELL; MALE;

EID: 76449090175     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0407-1     Document Type: Article

References (28)

1. SGO Johansson H Bennich 1967 Immunological studies of an atypical (myeloma) immunoglobulin Immunology 13 381 394 1:CAS:528:DyaF1cXitVGgtA%3D%3D 4168094
2. MJ Hayes JL Carey JC Krauss DL Hedstrom RL Gulbranson DF Keren 2007 Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma Eur J Haematol 78 353 357 10.1111/j.1600-0609.2007.00825.x 1:CAS:528:DC%2BD2sXkvFegsr0%3D 17378894 (Pubitemid 46365088)
3. JL Wozney F Ahmed MG Bayerl WC Ehmann G Talamo 2009 Skin involvement in immunoglobulin E multiple myeloma J Clin Oncol 27 637 638 10.1200/JCO.2008.20. 1491 19064952
4. L Lloyd SL Klingberg M Kende JF Howell AE Clague 2003 A case of IgE multiple myeloma Pathology 35 87 89 10.1080/0031302021000062424 1:CAS:528:DC%2BD3sXivVWlurc%3D 12701695
5. N Yamagata C Shimazaki H Goto T Hirata E Ashihara N Oku, et al. 1994 IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-α Am J Hematol 45 262 264 10.1002/ajh.2830450315 1:STN:280:DyaK2c7islCktw%3D%3D 8296801
6. B Van Camp BGM Durie C Spier M De Waele I Van Riet E Vela, et al. 1990 Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1, Leu-19) Blood 76 377 382 1695113
7. M Kraj U Sokołowska J Kopeć-Szlȩzak R Pogłód B Kruk J Woźniak, et al. 2008 Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma Leukemia Lymphoma 49 298 305 10.1080/10428190701760532 1:CAS:528:DC%2BD1cXhtFektLo%3D 18231917 (Pubitemid 351193923)
8. RC Ridley H Xiao H Hata J Woodliff J Epstein RD Sanderson 1993 Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen Blood 81 767 774 1:CAS:528:DyaK3sXht1ajs7c%3D 8427968
9. HF Barker MS Hamilton J Ball M Drew IM Franklin 1992 Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells Br J Haematol 81 331 335 10.1111/j.1365-2141.1992.tb08236.x 1:STN:280: DyaK3s%2Fgt1Chug%3D%3D 1382543
10. MS Mahmoud H Ishikawa R Fujii MM Kawano 1998 Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6 Blood 92 3887 3897 1:CAS:528:DyaK1cXnsVKlt7c%3D 9808582
11. + subpopulations that can proliferate in response to IL-6 in human myelomas Br J Haematol 105 131 140 10.1111/j.1365-2141.1999.01281.x 1:STN:280: DyaK1M3ltVGitA%3D%3D 10233376 (Pubitemid 29197155)
12. + immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005) Int J Hematol 83 39 43 10.1532/IJH97.05112 16443550 (Pubitemid 43172740)
13. H Avet-Loiseau R Garand L Lodé JL Harousseau R Bataille 2003 for the Intergroupe Francophone du Myélome. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants Blood 101 1570 1571 10.1182/blood-2002-08-2436 1:CAS:528:DC%2BD3sXht1ansrg%3D 12393502 (Pubitemid 36182536)
14. A Gabrea PL Bergsagel M Chesi Y Shou WM Kuehl 1999 Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell Mol Cell 3 119 123 10.1016/S1097-2765(00)80180-X 1:CAS:528:DyaK1MXpvFWktA%3D%3D 10024885 (Pubitemid 29292483)
15. P Pasqualetti V Festuccia A Collacciani P Acitelli R Casale 1996 Plasma cell leukemia. A report on 11 patients and review of the literature Panminerva Med 38 179 184 1:STN:280:DyaK2s7mt1yhsw%3D%3D 9009684
16. M Macro I André E Comby S Chèze F Chapon JJ Ballet, et al. 1999 IgE multiple myeloma Leukemia Lymphoma 32 597 603 1:STN:280: DyaK1M7ls1Wkuw%3D%3D 10048434
17. M Ogawa S Kochwa C Smith K Ishizaka OR McIntyre 1969 Clinical aspects of IgE myeloma N Engl J Med 281 1217 1220 1:STN:280:DyaE3c%2FisFGisQ%3D%3D 4186803
18. J Yoshitake S Hiramatsu Y Komatsubara T Matsubara T Fujita H Akutagawa, et al. 1976 A case of IgE myeloma Acta Haematol Jpn 39 862 875 1:STN:280:DyaE2s7pvVCmtA%3D%3D
19. JP Vaerman 1979 A new case of IgE myeloma (Des) ending with renal failure J Clin Lab Immunol 2 343 348 1:STN:280:DyaL3c7ktVelsg%3D%3D 119859
20. NC West AM Smith R Ward 1983 IgE myeloma associated with plasma cell leukaemia Postgrad Med J 59 784 785 10.1136/pgmj.59.698.784 1:STN:280: DyaL2c%2FpsFaksQ%3D%3D 6657539
21. ML Gallango R Suinaga M Ramírez 1988 IgE pyroglobulinemia in multiple myeloma Clin Chim Acta 176 151 156 10.1016/0009-8981(88)90202-1 1:STN:280:DyaL1M%2FivFWlsw%3D%3D 3180463 (Pubitemid 18193259)
22. KJA Kairemo M Lindberg M Prytz 1999 IgE myeloma: a case presentation and a review of the literature Scand J Clin Lab Invest 59 451 456 10.1080/00365519950185472 1:CAS:528:DC%2BD3cXkt1Sk 10612556
23. R García-Sanz A Orfão M González MD Tabernero J Bladé MJ Moro, et al. 1999 Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics Blood 93 1032 1037 9920853
24. C Pellat-Deceunynck S Barillé G Jego D Puthier N Robillard D Pineau, et al. 1998 The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma Leukemia 12 1977 1982 10.1038/sj.leu.2401211 1:STN:280:DyaK1M%2FlvFSlsw%3D%3D 9844928
25. CH Cha CJ Park JR Huh HS Chi CW Suh YK Kang 2007 Significant better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia Acta Haematol 118 178 182 10.1159/000109470 17934254 (Pubitemid 350014911)
26. M Abe K Hiura J Wilde K Moriyama T Hashimoto S Ozaki, et al. 2002 Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma Blood 100 2195 2202 1:CAS:528:DC%2BD38Xnt1yhsb4%3D 12200385
27. M Abe K Hiura J Wilde A Shioyasono K Moriyama T Hashimoto, et al. 2004 Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion Blood 104 2484 2491 10.1182/blood-2003-11-3839 1:CAS:528:DC%2BD2cXovVegtLc%3D 15187021 (Pubitemid 39331851)
28. T Hashimoto M Abe T Oshima H Shibata S Ozaki D Inoue, et al. 2004 Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma Br J Haematol 125 38 41 10.1111/j.1365-2141.2004.04864.x 1:CAS:528: DC%2BD2cXjsFOnsLs%3D 15015966 (Pubitemid 38453275)